Question Time AU

General Debate

Women's Health

House of Representatives · Monday 2 March 2026

Official Hansard for this day (APH) · Read this debate on OpenAustralia

At a glance

The debate centred on the progress of the Albanese government's landmark women's health package, with Labor members highlighting significant cost savings and increased access to treatments for menopause, endometriosis, and contraception. Opposition members acknowledged the bipartisan origins of some initiatives but criticised delays in PBS listings and rising out-of-pocket costs for primary care. Independent member Monique Ryan raised serious allegations regarding surgical practices at a private hospital, calling for stronger regulatory oversight. The motion was supported by the majority of speakers who emphasised the package's role in addressing historical neglect of women's health issues.

Outcome

The motion was agreed to without division.

Summary in reported speech - not a transcript. AI-generated, so check the official record before quoting.

How the debate unfolded

Opened the debate

Campbell moved the motion to note the government's delivery on its women's health package, citing that over 660,000 women had accessed more than 2 million cheaper prescriptions for birth control, hormone replacement for menopause, and treatments for endometriosis. Campbell highlighted that 383,000 women saved $53 million on menopause therapies and 328,000 saved $27 million on contraceptive pills, marking the first new listings for these categories in decades. Campbell noted the establishment of 33 endometriosis and pelvic pain clinics and the rollout of Medicare-funded menopause health assessments, which had been accessed by over 71,000 women. Campbell argued that the package addressed longstanding gaps in affordability and specialised care, supporting women's participation in the economy and improving individual wellbeing.

Opposition response

McIntosh noted that the women's health package built on bipartisan commitments made by the former Coalition government, including the initial establishment of endometriosis clinics. McIntosh welcomed the expansion of services but urged the government to list all medicines recommended by the Pharmaceutical Benefits Advisory Committee in a timely manner, citing a delay of over 12 months for the endometriosis treatment Ryeqo. McIntosh argued that rising out-of-pocket costs for general practitioner visits, which she claimed averaged more than $50, were undermining access to primary care for women managing chronic conditions. McIntosh stated that the Coalition would continue to hold the government accountable for delivery failures and rising costs that affected women's ability to afford health advice and check-ups.